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Abstract
The innate immune system including microglia has a major contribution to maintenance of the physiological functions of
the hippocampus by permanent monitoring of the neural milieu and elimination of tissue-damaging threats. The
hippocampus is vulnerable to age-related changes ranging from gene expression to network connectivity. The risk of
hippocampal deterioration increases with the decline of gonadal hormone supply. To explore the impact of hormone milieu
on the function of the innate immune system in middle-aged female rats, we compared mRNA expression in the
hippocampus after gonadal hormone withdrawal, with or without subsequent estrogen replacement using estradiol and
isotype-selective estrogen receptor (ER) agonists. Targeted profiling assessed the status of the innate immune system
(macrophage-associated receptors, complement, inhibitory neuronal ligands), local estradiol synthesis (P450 aromatase) and
estrogen reception (ER). Results established upregulation of macrophage-associated (Cd45, Iba1, Cd68, Cd11b, Cd18,
Fcgr1a, Fcgr2b) and complement (C3, factor B, properdin) genes in response to ovariectomy. Ovariectomy upregulated
Cd22 and downregulated semaphorin3A (Sema3a) expression, indicating altered neuronal regulation of microglia.
Ovariectomy also led to downregulation of aromatase and upregulation of ERa gene. Of note, analogous changes were
observed in the hippocampus of postmenopausal women. In ovariectomized rats, estradiol replacement attenuated Iba1,
Cd11b, Fcgr1a, C3, increased mannose receptor Mrc1, Cd163 and reversed Sema3a expression. In contrast, reduced
expression of aromatase was not reversed by estradiol. While the effects of ERa agonist closely resembled those of estradiol,
ERb agonist was also capable of attenuating the expression of several macrophage-associated and complement genes.
These data together indicate that the innate immune system of the aging hippocampus is highly responsive to the gonadal
hormone milieu. In ovariectomized female rats, estradiol replacement exerts potent immunomodulatory effects including
attenuation of microglia sensitization, initiation of M2-like activation and modulation of complement expression by
targeting hippocampal neurons and glial cells through ERa and ERb.
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Introduction
The hippocampus plays a crucial role in learning and memory,
and it is essential for planning and creativity [1]. This brain area is
vulnerable to age-related changes ranging from gene expression to
neuronal network connectivity [2,3]. Ongoing neurogenesis,
which helps to maintain normal hippocampal function, is impaired
dramatically during aging [4]. Age-related alterations are impli-
cated in the development of neurodegenerative diseases [5].
Changes in gene expression start at midlife [6], which overlaps
with the time of cessation of estrogen and progesterone synthesis
by the ovaries [7]. In rodents, alterations of the hippocampal
transcriptome also begin at midlife [8]. Estrogen and progesterone
receptors are expressed in the hippocampus [9–12]. ERa and ERb
are of particular interest as they mediate the effects of 17b-
estradiol (E2) on gene expression [13,14], intracellular signaling
[15,16] and synaptic plasticity [17,18]. Besides synaptic plasticity,
E2 modulates glial functions and regulates the immune response
[19–23]. By the time of menopause, declining gonadal hormone
supply is associated with increased risks of hippocampal deterio-
ration and memory disturbances [24,25].
Microglial cells, which form part of the innate immune system,
play an important role in the maintenance of hippocampal
functions via constant monitoring of the neural milieu to eliminate
tissue-damaging threats. In addition, surveying microglia acutely
modulate synaptic activity by regulating the number of functional
synapses in organotypic slices [26]. Microglia also remodel
neuronal circuits in the postnatal retinogeniculate system in an
activity and complement-dependent manner [27]. Microglial cells
express steroid hormone receptors [28]. While there is consensus
about the expression of ERa, expression of ERb is rather
controversial [28–31]. Independent studies have detected only
ERa at mRNA and protein level in microglia isolated from adult
mice [28,30]. Anti-inflammatory effects of E2 are mediated
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primarily through ERa [19], but a recent study has demonstrated
that the androgen metabolite 5-androsten-3b,17b-diol can sup-
press inflammatory processes of microglia and astrocytes via acting
through ERb [29]. Another laboratory has provided immunohis-
tochemical data that support ERb expression in mouse microglia
[31]. Progesterone and its metabolite allopregnanolone modify the
action of E2 and exert immunomodulatory effects [32]. Microglia
continuously survey the local environment via receptors for
neurotransmitters, danger signals, chemokines, cytokines and
complement activation fragments among others [33]. Receptors
for danger signals and inhibitory neuronal ligands represent the
accelerator and the break for the transition from surveying to
effector microglia, respectively [33].
In rat models of normal aging, molecular and functional
alterations of microglia indicate the elevation of microglia
reactivity. Microglial expression of MHCII [34,35] and other cell
surface markers such as CD11b [36], CD68 [37], CD80, CD86
[38] increases in the normal aged brain. The initial shift in
microglia phenotype may occur at midlife [6] coinciding with the
menopausal transition. Therefore, we hypothesize that menopause
upsets the delicate balance between activation signals and
inhibitory neuronal ligand control resulting in a shift of the
microglia phenotype in the aging female hippocampus.
Middle-aged ovariectomized rats are widely used to study
behavioral [39,40], cellular [41] and molecular [17,42] changes
related to menopause. Here, we studied the hippocampal
transcriptome of this animal model in order to explore the effects
of ovariectomy and subsequent estrogen replacement; transcripts
analyzed were related to the innate immune system including
microglia, complement (especially components of the alternative
pathway) and cytokines. In replacement studies we used E2 and
isotype-selective ER agonists. As the expression of macrophage-
associated genes is low in surveying microglia at this age [35], we
followed mRNA expression, which allowed us to quantitatively
typify gene expression. Results of the present study provide
evidence that ovariectomy of middle-aged rats increases the
expression of macrophage-associated receptors, components of the
alternative activation pathway of complement and inhibitory
neuronal ligands for microglia. We show that estrogen replace-
ment attenuates the shift in the microglia phenotype, partly
restores neuronal control of microglia and modulates complement
expression. These data suggest that ovariectomy-dependent
changes in the innate immune system can be attenuated by timely
estrogen replacement.
Materials and Methods
Ethics Statement
All studies were carried out with permission from the Animal
Welfare Committee of the Institute of Experimental Medicine,
Hungarian Academy of Sciences (Permission Number: A5769-01)
and in accordance with the legal requirements of the European
Community (Decree 86/609/EEC). Animal experimentation
described was conducted in accord with accepted standards of
animal care.
Reagents
E2 and diarylpropionitrile (DPN) were obtained from Sigma
(St.Louis, MO, USA) and Tocris (Ellisville, MO, USA), respec-
tively. 3,17b-dihydroxy-19-nor-17a-pregna-1,3,5(10)-triene-
21,16a-lactone (LE2) was synthesized and kindly provided for
this study by Gedeon Richter Plc [43]. Alzet osmotic minipumps
(model 2004) were purchased from Durect (Cupertino, CA, USA).
Reverse transcription reagents, microfluidic cards and PCR
master mixes were ordered from Applied Biosystems (Foster City,
CA, USA).
Treatments of Experimental Animals
Female Harlan-Wistar rats were purchased from Toxicoop
(Budapest, Hungary) and were housed under standard laboratory
conditions with unrestricted access to phytoestrogen-free rodent
diet (Harlan Teklad Global Diets, Madison, WI, USA). The
following experimental groups were applied: middle-aged (13
month old) female rats (M group), middle-aged ovariectomized
(OVX) rats (M/OVX group) and M/OVX rats with estrogen
replacement. Replacement was performed with E2 (M/OVX+E2
group), ERa agonist LE2 (M/OVX+LE2 group) and ERb agonist
DPN (M/OVX+DPN group). Middle-aged (n = 26) rats under-
went bilateral ovariectomy except for the sham-operated M group
(n= 8). All rats were housed individually after surgery, and ten
days later received treatments with vehicle or ER agonists.
Treatments in middle-aged OVX rats were carried out as
described earlier [43]. In brief, Alzet 2004 osmotic minipumps
filled either with E2 (0,33 mg/ml in propylene-glycol, n = 8), LE2
(3,33 mg/ml in propylene-glycol, n = 5), DPN (3,33 mg/ml in
propylene-glycol, n = 5), or the vehicle only (n = 8, M/OVX
group) were implanted subcutaneously for 29 days. Concentra-
tions of E2 and isotype-selective ER agonists were calculated to
produce a release rate of 2.0mg/d and 20 mg/d, respectively.
Treatments with E2 and LE2 at these doses result in a similar
increase in uterine weight, while DPN causes no change [43].
Body weights were measured to test efficacy of the treatments.
Sample Preparation
On the day of sample preparation, animals were deeply
anesthetized and perfused transcardially with 100 ml of cold
fixative solution containing 10% RNAlater (Qiagen, Heidelberg,
Germany) in phosphate buffered saline. In all experiments, the
same procedure was followed for the preparation of the
hippocampal formation.
Quantitative Real-time PCR
The hippocampi were prepared and total RNA was isolated
using the RNeasy Lipid Tissue Kit (Qiagen, Hilden, Germany).
RNA analytics included A260 nm/A280 nm readings using a
Nanodrop Spectrophotometer and capillary electrophoresis using
Nano RNA Chips on 2100 Bioanalyzer (Agilent, Santa Clara, CA,
USA). All RNA samples displayed high RNA integrity numbers
(RIN .8.2).
Custom TaqMan microfluidic cards were designed to study in
depth the regulation of ninety-six genes by quantitative real-time
PCR. Microfluidic cards (Applied Biosystems, Foster City, CA,
USA) were preloaded by the manufacturer with selected
inventoried assays for genes of our interest (Table 1). We used
glyceraldehyde-3-phosphate dehydrogenase and hypoxanthine
guanine phosphoribosyl-transferase as housekeeping genes. Ex-
pression of these genes did not vary among treatment groups of the
study. Each assay consisted of a FAM dye-labeled TaqMan MGB
probe and two PCR primers. Reverse transcription and real-time
PCR were run as described earlier [43]. The ViiA7 RUO (Applied
Biosystems) software and relative quantification against calibrator
samples (DDCt) were used for data analysis. A computed internal
control corresponding to the geometric mean of cycle threshold
(Ct) values of the selected housekeeping genes was used for DCt
calculation [44]. The use of TaqMan chemistry allowed compar-
ison of DCt values which correlated with transcript levels. Based
on DCt values, macrophage-associated genes were ranked into
three categories based on their abundant (0,DCt,1), moderate
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(1,DCt,5) or low (DCt.5) level of mRNA expression. Relative
quantity (RQ=22DDCt) was used to characterize gene expression
in the various experimental groups. PCR experiments conformed
to minimum information for publication of quantitative real-time
PCR experiments (MIQE) guidelines [45].
Analysis of Human Microarray Data
The files of data set GSE11882 [6], deposited in Gene
Expression Omnibus, contained microarray data from the
hippocampus. Sample size (n), average age (age) in years and
standard deviation of ages (SD) were used to characterize the
premenopausal (nHC=9, ageHC= 39.4, SDHC= 8.0) and post-
menopausal (nHC= 5, ageHC= 71.2, SDHC= 4.4) hippocampus
data. Pre- and postmenopausal groups consisted of nine and five
individuals, respectively. Only changes with fold change (FC).1.5
(upregulation) and FC,0.66 (downregulation) were considered as
FC is the most reliable parameter in the case of low sample
numbers [46]. Raw microarray data were pre-processed for
analysis by GC robust multi-array average (GCRMA) [47]. From
the expression set, probesets were selected based on the relevance
to rat data.
Statistical Analysis
In PCR data evaluation, group data were expressed as
RQ(mean)6standard deviation (SD). Statistical significance of
the changes in gene expression was analyzed using ANOVA
followed by Newman-Keuls post-hoc test (Statistica software
version 11.0, StatSoft Inc., Tulsa, OK). Homocedasticity and
normality satisfied the criteria for running ANOVA. In correlation
analysis Pearson’s coefficient was estimated.
In microarray data evaluation, difference analysis of gene
expression was performed by linear models combined with
Bayesian methods [48], p was adjusted by the false discovery
rate-based method [49]. In statistical and data mining work,
Bioconductor packages [50] in R-environment were used.
Results
Expression of Immune-related Genes in the
Hippocampus of Middle-aged Female Rats
We investigated mRNA expression of macrophage-associated
genes (Table 1) in the hippocampus. Under physiological
conditions, these genes are expressed predominantly in microglial
cells, although in the case of toll-like receptors astroglial expression
has also been reported [51]. Among macrophage-associated genes,
we measured moderate to low mRNA level of microglia response
factor Iba1 and Fcgr2a, the rest of the genes tested had low mRNA
levels indicating a very weak macrophage character of microglia in
the hippocampus of middle-aged female rats. On the other hand,
microglial receptors for inhibitory neuronal ligands showed
significant expression. We detected high mRNA level of signal-
regulatory protein a (Sirpa), moderate levels of neuropilin 1
(Nrp1), fractalkine receptor (Cx3cr1), low levels of leukocyte
common antigen (Cd45) and very low levels of Cd200r (Table 1).
We also investigated the expression of complement and
proinflammatory cytokine genes (Table 2). Both neurons and glial
cells express complement components and their regulators. We
found moderate mRNA levels of C3, Cfh, Crry and Cd59, other
complement genes had low expression levels. We measured very
low levels of proinflammatory cytokine mRNAs (Table 2).
Impact of Ovarian Hormone Depletion and Subsequent
Estrogen Treatment on the Expression of Macrophage-
associated Genes
We examined the effect of ovarian hormones on mRNA
expression of macrophage-associated genes that encode microglial
markers, phagocytic receptors, recognition molecules and recep-
tors for inhibitory neuronal ligands.
Regulation of microglial marker genes. In middle-aged
OVX rats, expression of Iba1 (Fig. 1A) and Cd68 (Fig. 1B)
increased 1.2-fold (p = 0.036) and 1.8-fold (p = 0.027), respectively,
compared to middle-aged controls. Cd80 showed a similar
Table 1. Expression of macrophage-associated genes and
inhibitory neuronal ligands in the hippocampus of middle-
aged female rats.
TaqMan ID DCt
MACROPHAGE-ASSOCIATED GENES
markers
Iba1 Rn00574125_g1 4.982
Cd68 Rn01495634_g1 8.305
Cd80 Rn00709368_m1 10.30
Cd86 Rn00571654_m1 7.886
RT1-EC2 Rn03034964_u1 8.432
Cd74 Rn00565062_m1 3.941
Mrc1 Rn01487342_m1 8.548
Cd163 Rn01492519_m1 9.177
phagocytic receptors
Cd11b Rn00709342_m1 5.333
Cd18 Rn01427948_m1 6.386
Fcgr1a Rn01762682_m1 8.407
Fcgr2b Rn00598391_m1 6.818
Fcgr2a Rn00821543_g1 4.860
recognition receptors
Cd14 Rn00572656_g1 9.929
Tlr3 Rn01488472_g1 9.142
Tlr4 Rn00569848_m1 7.975
Tlr9 Rn01640054_m1 8.768
receptors for inhibitory neuronal ligands
Cd45 Rn00709901_m1 7.350
Nrp1 Rn00686106_m1 1.981
Sirpa Rn00564609_m1 0.845
Cd200r1 Rn00576646_m1 11.53
Cx3cr1 Rn02134446_s1 3.657
NEURONAL GENES
inhibitory ligands for microglia
Cd22 Rn01457837_m1 10.54
Sema3a Rn00436469_m1 7.487
Cd47 Rn01763248_m1 4.125
Cd200 Rn01646320_m1 3.268
Cx3cl1 Rn00593186_m1 0,168
mRNA expression was studied by real-time PCR using TaqMan chemistry. DCt
represents the difference between the Ct of a given gene and of the
endogenous control (geometric mean of the Ct values of the selected
housekeeping genes glyceraldehyde-3-phosphate dehydrogenase and
hypoxanthine guanine phosphoribosyl-transferase, 21.88760.296). Ct, cycle
threshold.
doi:10.1371/journal.pone.0088540.t001
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increase as Iba1 (RQ=1.367, p = 0.052), whereas Mrc1 (Fig. 1C),
Cd163 (Fig. 1D) and Cd86 (data not shown) did not change after
ovariectomy. Subsequent E2 replacement attenuated ovariectomy-
evoked upregulation of Iba1 (Fig. 1A) and Cd68 (Fig. 1B). In
addition, E2 increased mRNA expression of Mrc1 (Fig. 1C) and
Cd163 (Fig. 1D) compared to middle-aged control rats. In order to
assess the contribution of the two ER isotypes to E2 responses,
chronic treatments were carried out with either the ERa agonist
LE2 [52] or the ERb agonist DPN [53]. Both LE2 and DPN
mitigated ovariectomy-induced upregulation of Iba1 and Cd68.
Only inhibition of Iba1 expression by DPN reached statistical
significance compared to M/OVX animals. Similar to E2, LE2
enhanced the expression of Mrc1 and Cd163 compared to M and
M/OVX animals (Fig. 1).
We also explored hormonal regulation of two MHC genes,
RT1-EC2 and Cd74. Ovariectomy evoked 2.1-fold increase in
mRNA expression of RT1-EC2 (p = 0.031) compared to middle-
aged controls. Estrogen treatments did not attenuate the
alteration. Cd74 showed no hormonal regulation in the hippo-
campus.
Regulation of phagocytic receptor genes. All phagocytic
receptor genes except low affinity FccR (Fcgr2b) showed
moderate, but significant upregulation in middle-aged OVX rats
compared to controls. For example, complement receptor 3
subunits Cd11b (Fig. 2A) and Cd18 (Fig. 2B) mRNA expression
increased 1.6-fold (p = 0.008) and 1.2-fold (p = 0.025), respectively.
Expression of FccRs including Fcgr1a (RQ=1.413, p = 0.046) and
Fcgr2b (RQ=1.437, p = 0.011) also increased after ovariectomy.
E2 replacement attenuated ovariectomy-induced upregulation of
Cd11b (Fig. 2A), Cd18 (Fig. 2B) and Fcgr1a (data not shown)
compared to middle-aged controls. Alterations reached statistical
significance compared to M/OVX animals. Isotype-selective ER
agonists also reduced the expression of Cd11b and Cd18. In turn,
Table 2. Expression of complement and cytokine genes in
the hippocampus of middle-aged female rats.
TaqMan ID DCt
COMPLEMENT AND CYTOKINE GENES
complement and complement regulators
C1qa Rn01519903_m1 6.625
Serping1 Rn01485600_m1 6.023
C3 Rn00566466_m1 4.864
Cfb Rn01526084_g1 6.618
Cfd Rn01535436_g1 8.955
Cfh Rn00590326_m1 4.580
Cfp Rn01430864_m1 9.820
Crry Rn00570775_m1 4.068
Cd55 Rn00709472_m1 7.447
Cd59 Rn00563929_m1 2.963
proinflammatory cytokines
Tnf Rn01525859_g1 10.141
Il1b Rn00580432_m1 13.147
Il6 Rn01410330_m1 11.088
Il12b Rn00575112_m1 18.053
mRNA expression of complement and proinflammatory cytokine genes was
measured by real-time PCR using TaqMan assays. DCt represents the difference
between Ct of a given gene and of the endogenous control. Ct, cycle threshold.
doi:10.1371/journal.pone.0088540.t002
Figure 1. The effect of ovariectomy and treatment with E2 and
isotype-selective ER agonists on mRNA expression of microglia
marker genes. Expression of microglia marker Iba1 (A), Cd68 (B), and
M2 marker Mrc1 (C) and Cd163 (D) in the hippocampus of middle-aged
(M), middle-aged ovariectomized (M/OVX) and M/OVX rats treated with
E2 (M/OVX+E2), LE2 (M/OVX+LE2) and DPN (M/OVX+DPN) was
determined by real-time PCR. Error bars show SD of five samples for
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neither E2 nor the ER agonists attenuated the expression of
Fcgr2b.
Regulation of recognition receptors. Among recognition
molecules, we found upregulation of Tlr3 (RQ=1.755, p= 0.003)
(Fig. 2C) and Tlr9 (RQ=1.369, p = 0.042) (Fig. 2D) in ovariec-
tomized rats compared to controls. Chronic treatment with E2
decreased Tlr9 expression (Fig. 2D), but did not alter Tlr3. Only
DPN was effective to reduce mRNA expression of Tlr9 (Fig. 2D).
Regulation of regulatory receptors. Among microglial
receptors for inhibitory neuronal ligands, mRNA expression
Cd45 (Fig. 3A) and Cd200r (Fig. 3B) increased 1.2-fold
(p = 0.049) and 1.5-fold (p = 0.037), respectively, in ovariectomized
rats compared to controls. Nrp1 (Fig. 3C), Sirpa and Cx3cr1
expression did not alter. E2 replacement and chronic treatments
with isotype-selective ER agonists increased mRNA expression of
regulatory receptors (Fig. 3). Of note, E2 and LE2 significantly
enhanced expression of Cd200r compared to M/OVX rats
(Fig. 3B).
Ovariectomy modulated expression of genes encoding inhibi-
tory neuronal ligands for microglia as well. Expression of Cd22
enhanced 2.5-fold (p,0.001) (Fig. 4A), of Sema3a decreased 1.6-
fold (p = 0.001) (Fig. 4B). Other inhibitory neuronal ligands
including Cd47, Cd200 (Fig. 4C), Cx3cl1 did not change after
ovariectomy. Only Sema3a expression was reversed by treatments
with E2 and ERa agonist LE2 (Fig. 4B).
In addition, we investigated the expression of four astroglial
markers including glial fibrillary acidic protein, colony stimulating
factor 1, and glial high affinity glutamate transporters (Slc1a2,
Slc1a3). These genes showed negligible alterations (data not
shown).
Effect of Ovarian Hormones and Isotype-selective ER
Agonists on the Expression of Complement Genes
Neurons and glial cells express complement components and
their regulators [54]. The classical and alternative complement
activation pathways converge at C3 activation resulting in the
release of C3a and generation of iC3b on the surface of cells
rendered to phagocytosis [55]. Expression of C3, the central
component of complement increased 1.9-fold (p = 0.001) in
ovariectomized rats compared to controls (Fig. 5A). Factor B
(Cfb), subunit of the alternative pathway C3 convertase C3bBb,
showed similar but smaller (1.3-fold, p = 0.037) increase in mRNA
expression than C3 (Fig. 5B). Factor D (Cfd) showed no alteration
following ovariectomy. Negative regulators of C3bBb such as
factor H (Cfh) (Fig. 5C), complement regulatory protein (Crry) and
Cd55 did not change. Expression of positive regulator of C3bBb,
properdin (Cfp) increased 1.5-fold (Fig. 5D), but the change did
not reach statistical significance (p = 0.116). Cd59, an inhibitor of
homologous complement lysis showed unaltered expression.
Chronic treatments with E2 and DPN reversed upregulation of
C3, while LE2 did not (Fig. 5A). In contrast, E2 and LE2 increased
mRNA expression of genes encoding components of the alterna-
tive pathway (Fig. 5B–D). In the case of Cfb, DPN showed a
character different from E2, i.e. restored mRNA expression
(Fig. 5B).
each group. ANOVA identified statistically significant treatment effects
for each gene (p = 0.009 for Iba1, p = 0.014 for Cd68, p,0.001 for M2
markers). Turquoise, black and red asterisks mark statistically significant
group differences compared to M, M/OVX and M/OVX+E2 animals,
respectively, by Newman-Keuls post hoc test. * corresponds to 0.01,
P,0.05 and *** to P,0.001. M, middle-aged female rat; M/OVX, middle-
aged OVX rat; M/OVX+E2, M/OVX rats treated with E2; M/OVX+LE2,
treated with 16a-LE2; M/OVX+DPN, treated with DPN. P, p value.
doi:10.1371/journal.pone.0088540.g001
Figure 2. Ovariectomy-evoked changes in the expression of
phagocytic and recognition receptors were responsive to ER
agonists.mRNA expression of Cd11b (A), Cd18 (B), Tlr3 (C) and Tlr9 (D)
in the hippocampus was determined by real-time PCR. Error bars show
SD of five samples for each group. ANOVA identified statistically
significant differences in gene expression among treatment groups for
all genes (p,0.001 for Cd11b, p = 0.012 for Cd18, p,0.001 for Tlr3,
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We examined mRNA expression of Tnfa, Il1b, Il6 and Il12b,
which showed no regulation by ovarian hormones (data not
shown). We also tested expression of anti-inflammatory cytokines
Il4 and Il10, but their mRNA levels were below the detection limit
of TaqMan-based real-time PCR.
Ovarian Hormone-dependent Regulation of Aromatase
and Estrogen Receptor Genes
In the absence of circulating E2, local synthesis determines the
actual E2 concentration in the hippocampus of OVX rats. In this
process, cytochrome P450 aromatase (encoded by Cyp19a1)
carries out hydroxylation of the A ring of androgen precursors,
androstendione and testosterone [56]. Cyp19a1 expression
showed 1.4-fold (p = 0.025) decrease in middle-aged OVX rats
compared to controls (Fig. 6A). E2 and isotype-selective ER
agonists did not restore mRNA expression of Cyp19a1, LE2 even
decreased it further (Fig. 6A). It is known that aromatase activity
has been involved in many functions, from synaptogenesis to
neuroprotection [57]. In accord with decreased Cyp19a1, we
found downregulation of growth associated protein 43
(RQ=0.827, p = 0.018) and synaptophysin (RQ=0.876,
p = 0.022). We examined the correlation between the expression
of Gap43, Cyp19a1 and macrophage-associated genes. In M/
OVX animals, Pearson’s correlation analysis revealed positive
correlation between Gap43 and Cyp19a1 (R=0.73, p = 0.162),
and negative correlation between Gap43 and Cd11b (R=20.92,
p = 0.077), Cyp19a1 and Cd11b (R=20.81, p= 0.094), Cyp19a1
and Cd22 (R=20.88, p= 0.052). These results suggested that a
positive correlation might exist between the expression of Gap43
and Cyp19a1 in the hippocampus of middle-aged OVX rats. In
addition, strong negative correlation might exist between the
expression of Gap43 and Cd11b, Cyp19a1 and Cd22.
Among ER genes, Esr1, encoding ERa, was upregulated 1.4-
fold (p = 0.033) in OVX rats compared to controls (Fig. 5B). The
expression of Esr2 (Fig. 5C) and Gper encoding ERb and GPR30,
respectively, did not change after ovariectomy. E2 attenuated
mRNA expression of Esr1, while isotype-selective ER agonists did
not (Fig. 5B). E2 and DPN significantly reduced expression of Esr2
compared to M/OVX animals (Fig. 5C).
Data Analysis Reveals Upregulation of Macrophage-
associated Genes and Complement in Postmenopausal
Women
In order to address the effect of menopause on the innate
immune system in the hippocampus, we compared the expression
of selected genes in raw microarray data of pre- and postmeno-
pausal women [6]. We identified a large series of changes related
to menopause (and aging) that were strikingly similar to those
induced by ovariectomy in middle-aged rats. These included
upregulation of CD22 (FC=2.4), CD45 (FC=2.3), CD11b
(FC=1.5), CD18 (FC=5.1), IBA1 (FC=1.7), CD14 (FC=4.1),
C3 (FC=2.1), and down-regulation of GAP43 (FC=0.55), SYP
(FC=0.61), SEMA3A (FC=0.756). Additional similarities includ-
ed unaltered expression of astroglia markers and proinflammatory
cytokines.
Discussion
Focusing on the innate immune system in the hippocampus, we
studied the impact of ovarian hormone deficiency and subsequent
estrogen treatments with E2 and isotype-selective ER agonists on
gene expression in middle-aged female rats. From the results we
conclude that ovarian hormone deficiency alerts the innate
immune system in the hippocampus, and subsequent E2
replacement is capable of counteracting several changes via ERa
and ERb. Our findings are in line with previous reports that have
demonstrated relationship between endogenous estrogen status
and microglia reactivity [20], escape of microglia from inhibitory
neuronal control [58], activation of microglia [34,35,59] and
enhanced complement expression in the normal aged brain
[6,8,60].
Ovariectomy Alerts the Innate Immune System in the
Hippocampus
Ovariectomy sensitizes microglia. Microglia show plastic-
ity and possess various priming states that determine the microglial
response to subsequent stimuli. Most studied examples include the
classical (M1) and alternative (M2) priming states that evolve in
response to interferon-c and IL4 (or IL13), respectively. In
response to ovarian hormone deficiency, we find elevated
expression of several microglia markers (Iba1, Cd68, Cd80),
phagocytic receptors (Cd11b, Cd18, Fcgr1a, Fcgr2b) and recog-
nition molecules (Tlr3, Tlr9) in the hippocampus. Despite elevated
expression of macrophage-associated genes, glial cells do not
produce proinflammatory cytokines including tumor necrosis
factor a (TNFa). This is in accord with the finding of a recent
study demonstrating that while age-dependent microglial NF-kB
activation and TNFa overproduction take place in the hypothal-
amus, only minor NF-kB activation occurs in the cerebral cortex
of middle-aged mice [61]. On the other hand, several studies have
reported elevated cytokine production in aging microglia isolated
from rats and mice. Enhanced production of cytokines in aged
microglia may represent age-related alterations. The apparent
disagreement between the findings in aged and middle-aged
animals suggests that in middle-aged female rats, elevation of
cytokine production has not started yet.
The alterations in hippocampal gene expression suggest
sensitization of microglia, characterized by moderate upregulation
of Iba1, Cd68, Cd11b, Cd18, Fcgr1a, Fcgr2b and Cd80. Of note,
mRNA expression of Cd74, Cd86, Cd163, Mrc1, Fcgr2b, Cd14,
Tlr4 does not change after ovariectomy. Analysis of human
microarray data and comparison between pre- and postmeno-
pausal individuals reveal analogous changes in the expression of
these genes indicating that microglia sensitization may occur in
postmenopausal women. This special phenotype suggests that
microglia adapt and maintain homeostasis by increasing the
expression of phagocytic receptors and co-receptors to possess
enhanced phagocytic potential.
Ovariectomy alters the neuronal control of microglia
reactivity. CD22, formerly known as B-lymphocyte cell adhe-
sion molecule, is expressed in rodent neurons [62]. Neurons
secrete a soluble form of CD22, which inhibits microglial
activation and proinflammatory cytokine production in vitro via
CD45 [62]. CD45 is the most abundantly expressed transmem-
brane protein-tyrosine phosphatase. Quiescent microglial cells
constitutively express CD45, which elevates further during
activation [63]. We find weak mRNA expression of Cd22 and
Cd45 in the hippocampus of middle-aged female rats, both of
which increase after ovariectomy. In agreement with elevated
expression of Cd22 and Cd45, mRNA expression of proinflam-
p= 0.009 for Tlr9). Turquise, black and red asterisks mark statistically
significant group differences compared to M, M/OVX and M/OVX+E2
animals, respectively, by Newman-Keuls post hoc test. * corresponds to
0.01,P,0.05 and ** to 0.001,P,0.01.
doi:10.1371/journal.pone.0088540.g002
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Figure 3. Ovarian hormone depletion and treatment with ER agonists induced changes in mRNA expression of microglial receptors
for inhibitory neuronal ligands. Expression of Cd45 (A), Cd200r1 (B) and Nrp1 (C) in the hippocampus was measured by real-time PCR. Error bars
show SD of five samples for each group. ANOVA revealed statistically significant treatment effects for each gene (p = 0.002 for Cd45, p = 0.014 for
Nrp1, p,0.001 for Cd200r1). Turquoise, black and red asterisks mark statistically significant group differences compared to M, M/OVX, M/OVX+E2
animals, respectively, by Newman-Keuls post hoc test. * corresponds to 0.01,P,0.05, ** to 0.001,P,0.01 and *** to P,0.001.
doi:10.1371/journal.pone.0088540.g003
Estrogens Tune Innate Immune System in Hippocampus
PLOS ONE | www.plosone.org 7 February 2014 | Volume 9 | Issue 2 | e88540
Figure 4. Ovariectomy and subsequent ER agonist treatments modulated mRNA expression of inhibitory neuronal ligand genes.
Expression of Cd22 (A), Sema3a (B) and Cd200 (C) in the hippocampus was measured by real-time PCR. Error bars show SD of five samples for each
group. There were statistically significant treatment effects in the case of Cd22 and Sema3a (p value of the ANOVA was smaller than 0.001 in both
cases, p = 0.328 for Cd200). Turquoise, black and red asterisks indicate significant group differences compared to M, M/OVX, M/OVX+E2 animals,
respectively, by Newman-Keuls post hoc test. * corresponds to 0.01,P,0.05, ** to 0.001,P,0.01 and *** to P,0.001.
doi:10.1371/journal.pone.0088540.g004
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matory cytokines does not change significantly either. Interesting-
ly, these alterations are reminiscent to those we observed in the
hippocampus of postmenopausal women. These results suggest
that in OVX rats and postmenopausal women neurons enhance
inhibitory CD22-CD45 signaling which prevents the transition
from surveying to effector microglia.
Ovariectomy induces a moderate increase in Cd200r1 expres-
sion in middle-aged rats. This finding suggests that in the
hippocampus of ovarian hormone deprived animals microglial
cells enhance the expression of receptors for inhibitory ligands
including Cd45 and Cd200r1. On the other hand, mRNA
expression of Cx3cr1, Nrp1 and Sirpa does not change in middle-
aged ovariectomized rats.
Another characteristic change which may contribute to the
alteration of neuron-microglia communication is the decrease of
Sema3a expression. Of note, downregulation of SEMA3A takes
place in postmenopausal woman as well. Neurons secrete
Sema3A, which can navigate axons, regulate neuronal polariza-
tion [64] and facilitate axonal transport [65]. Stressed neurons also
secrete Sema3A, which promotes microglial production of growth
factors and anti-inflammatory cytokines in vitro [66]. Sema3A also
induces apoptosis of activated microglia [67] indicating that
stressed neurons can protect themselves from activated microglia.
Therefore, decreased expression of Sema3a may modulate both
neuronal and glial functions via the aforementioned mechanisms.
Ovariectomy upregulates C3, factor B and
properdin. Complement is a powerful proteolytic cascade
which participates in the elimination of invading pathogens,
apoptotic cells, and in the regulation of the innate immune
response and inflammatory reactions [68]. Age-dependent upre-
gulation of C1q and C3 has been described in the rodent and
human brain [6,8,60]. We show ovarian hormone-dependent
upregulation of C3 in the hippocampus of middle-aged ovariec-
tomized rats and postmenopausal women. In middle-aged rats, we
find low level expression of components of the alternative
pathway, and observe upregulation of Cfb and properdin after
ovariectomy. Increased expression of alternative pathway compo-
nents can result in elevated tick-over [69], properdin-dependent
[70] and amplification mechanisms [71]. However, expression of
complement regulators such as Crry and Cd55 does not change. It
has potential functional significance as activation of the alternative
pathway may be connected to the initial activation of microglial
cells. In mice, deletion of Crry induces microglial priming, but
inactivation of the alternative pathway in Crry2/2 suspends the
shift in the phenotype suggesting that the alternative pathway may
play a role in microglia activation [72]. Apparent coincidence in
the alterations of macrophage-associated and complement gene
expression tempts us to speculate that elevated expression of C3,
Cfb and Cfp may contribute to the initial activation of microglial
cells after the cessation of ovarian hormone synthesis.
Ovariectomy alters expression of cytochrome P450
aromatase and ERa. Local estrogen synthesis in the hippo-
campus provides high E2 concentration [56,73]. We show that
expression of Cyp19a1 aromatase decreases in the absence of
circulating ovarian hormones. Earlier studies have demonstrated
that expression of synaptic proteins is regulated by aromatase
activity in the hippocampus [56]. In concert with decreased Cyp19
expression, we find down-regulation of synaptic marker genes
including Gap43 and Syp. These findings suggest that local E2
level may decrease after the loss of circulating E2 and progesterone
Figure 5. Ovariectomy and ER agonists modified the expres-
sion of complement genes. Expression of C3 (A), Cfb (B), Cfh (C) and
Cfp (D) in the hippocampus of M, M/OVX, M/OVX+E2, M/OVX+LE2 and
M/OVX+DPN rats was quantified by real-time PCR. Error bars show SD of
five samples for each group. ANOVA identified statistically significant
treatment effects for each gene (p,0.001 for C3 and Cfb, p = 0.002 for
Cfh and Cfp). Turquoise, black and red asterisks mark significant group
differences compared to M, M/OVX and M/OVX+E2 animals, respec-
tively, by Newman-Keuls post hoc test. * corresponds to 0.01,P,0.05,
** to 0.001,P,0.01 and *** to P,0.001.
doi:10.1371/journal.pone.0088540.g005
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Figure 6. The impact of gonadectomy and ER agonist treatments on mRNA expression of aromatase and ER genes in the
hippocampus of middle-aged OVX rats. Expression of Cyp19a1 (A), Esr1 (B) and Esr2 (C) was measured by real-time PCR. ANOVA revealed
statistically significant treatment effects for each gene (p,0.001 for Cyp19a1, p = 0.006 for Esr1 and p=0.028 for Esr2). Turquoise, black and red
asterisks indicate statistically significant group differences compared to M, M/OVX and M/OVX+E2 animals, respectively, by Newman-Keuls post hoc
test. * corresponds to 0.01,P,0.05, ** to 0.001,P,0.01 and *** to P,0.001.
doi:10.1371/journal.pone.0088540.g006
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from ovarian sources. We reveal that in middle-aged rats
ovariectomy increases ERa expression, but has no effect on ERb
and GPR30 in the hippocampus. It is important to note that these
results reflect the changes of gene expression from a wide range of
cell types including neurons, astrocytes and microglia. It is known
that at hippocampal synapses ERa is predominantly concentrated
presynaptically and highly enriched with synaptic vesicles [74].
Age decreases ERa level and/or localization in the hippocampus
[11]. Taking together, following ovariectomy hippocampal neu-
rons and glia respond to the sudden drop of serum levels of
ovarian hormones by downregulation of aromatase, upregulation
of macrophage-associated genes and receptors for inhibitory
neuronal ligands. Altered expression of inhibitory neuronal ligands
may contribute to maintain the tight control of microglia reactivity
in middle-aged female rats.
E2 Replacement Modulates the Expression of
Macrophage-associated Genes via ERa and ERb
Ovariectomy induces a mild change in the phenotype of
microglial cells. E2 replacement restores the alterations in the case
of Iba1, Cd68, Cd11b and Cd18. These genes are likely to be
regulated only by E2, i.e. progesterone does not modulate them.
Both ERa and ERb agonist treatments mitigate mRNA expression
of these genes. Of note, E2 replacement does not reverse
ovariectomy-evoked upregulation of Fcgr2b and Tlr3. These
genes are likely to be regulated by E2 and progesterone. In
addition, E2 and ERa agonist LE2 treatments trigger a marked
increase in mRNA expression of Mrc1 and Cd163, which are
widely used as M2 activation markers [75,76], indicating that E2
may differently regulates Mrc1 and Cd163 in the presence or in
the absence of progesterone. These findings are in agreement with
previous data demonstrating the role of ERa in the estrogenic
regulation of microglia [19,28,30]. On the other hand, inhibition
of Iba1, Cd68, Cd11b and Cd18 mRNA expression by ERb
agonist DPN may support the view that microglia also express
ERb [29,31]. However, we can not exclude the possibility that the
effect of DPN is an indirect effect, i.e. the result of the interaction
of microglia with other cell types.
Neuronal control of microglia reactivity has also significant
impact on the innate immune system of the brain [77]. Of note,
E2 and isotype-selective ER agonists enhance the expression of
microglial receptors for inhibitory neuronal ligands including
Cd45, Cd200r1 and Nrp1. The E2-like effects of DPN on the
expression of Cd45 and Nrp1 can support the notion that
microglial cells express low level of ERb. However, different effects
of E2 and DPN on Cd200r expression do not confirm the presence
of ERb in microglia. Estrogens affect the expression of inhibitory
neuronal ligands as well. E2 replacement reverses Sema3a
expression primarily via ERa, although ERb agonist DPN is also
effective. Neither E2 nor isotype-selective ER agonists turn the
elevation of Cd22 expression in OVX rats.
Summing up, our findings indicate that the innate immune
system of the hippocampus in middle-aged rats is responsive to the
gonadal hormone milieu. Ovariectomy triggers sensitization of
microglia, elevation of complement expression especially compo-
nents of the alternative pathway, and decline of aromatase level.
Although E2 replacement does not influence mRNA expression of
aromatase, E2 decreases the expression of microglia markers and
phagocytic receptors in part, and increases M2 activation markers
indicating a shift towards a protective microglia phenotype. E2
also modulates complement expression, attenuates C3 and
enhances Cfb, Cfh expression. In addition, E2 partly restores
Sema3A. The ERb agonist DPN attenuates both microglia
sensitization and complement expression. Our results suggest that
the innate immune system is responsive to estrogen replacement,
at least for a short period of time after ovariectomy.
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